???global.info.a_carregar???
My academic career began with a degree in biochemistry at the University of Aveiro. My degree project focused on several analytical methods: Flame Ionization Detector (FID) Gas Chromatography (GC-FID) and Gas Chromatography Mass Spectrometry (GC-MS) for quantification of monosaccharides and disaccharides to allow the characterization of locust been gum for the microencapsulation of insulin for pulmonary administration. I also worked with High Performance Liquid Chromatography (HPLC) to detect and study insulin release over time, as a preliminary pharmacokinetic study. I decided to take a Master's degree in Biochemistry, this time at the University of Porto. There I discovered and learned about Cardio-oncology and Toxicology, the two main areas of my thesis: ‘The study of the cardiotoxicity of oncological drugs and the study of a possible link between cardiotoxicity and oxidative stress’. During my Master's thesis, I had the opportunity to participate in different conferences. I was presenting author of several oral and poster presentations, being selected twice by the TOX-RUN Scientific Committee for oral presentation, in 2023 and 2024 (the latter presentation will take place at the beginning of May). Furthermore, I was awarded the best poster at the 18th YES Meeting, where I had to defend my scientific work (I chose this award as my representative scientific work). My thesis work, which related to Nrf2, a cellular transcription factor, allowed me to apply for a COST BenBedPhar (Action CA20121) Training School on Nrf2, which, if approved, I will attend in September 2024 in Poland, with full support of my supervisor, a member of that COST action. This year, I am also competing to a scholarship to present my work at EUROTOX 2024 in Denmark, in September this year. (I attached those applications on Annex section). During these last months, while finishing the work to write my first paper as first author, I had the opportunity to collaborate with other groups and colleagues, which allowed to be co-author of already published article, as second author, and two others have been submitted (one on cardiotoxicity of anti-viral drugs and another on oxidative stress on D. mellitus) I also had the opportunity to engage on other tasks, having mentored two girls in 2023 in the Student Exchange Program, which allows pharmaceutical science students from other countries to get in touch with the Portuguese professional reality. At present, I am co-supervisor of Ana Sofia, a biochemistry degree student, who is carrying out her degree project entitled “Characterization of an In Vitro Model of Human Heart Cells”, a challenging but very enriching experience. I would also like to highlight my three years of experience as a tutor, which has not only served as a means of supporting myself but has also provided me with invaluable opportunities to refine my teamwork skills, deal with diverse personalities, enhance my overall social abilities and go deeply into fundamental scientific concepts, all key in science.
Identificação

Identificação pessoal

Nome completo
Cláudia Vitorino-Oliveira

Nomes de citação

  • Vitorino-Oliveira, Cláudia

Identificadores de autor

Ciência ID
9C12-817F-4650
ORCID iD
0009-0009-1541-9465

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1)
Formação
Grau Classificação
2025/01/01 - 2029
Em curso
Ciências Farmacêuticas (Doutoramento)
Especialização em Toxiciologia
Universidade do Porto Faculdade de Farmácia, Portugal
2025/01/29
Concluído
Flow Cytometry: from basic knoledge to clinical applications (Curso de Especialização Tecnológica)
Universidade do Porto Faculdade de Farmácia, Portugal
20
2021/09/01 - 2023/11/17
Concluído
Bioquímica (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"Nrf2 modulators as pharmacological strategies to tackle the cardiotoxicity of anti-cancer drugs: a cardio-oncology in vitro study in human cardiac AC16 cells" (TESE/DISSERTAÇÃO)
17
2018/09/10 - 2021/07/20
Concluído
Bioquímica (Licenciatura)
Universidade de Aveiro, Portugal
15
Percurso profissional

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2024/01/01 - 2029 PhD student Unidade de Ciências Biomoleculares Aplicadas, Portugal
Universidade do Porto Faculdade de Farmácia, Portugal
Produções

Publicações

Artigo em conferência
  1. Vitorino-Oliveira, Cláudia; Kahremany, Shirin; Nissim, Laura; Duarte-Araújo, Margarida; Carvalho, Félix; Gruzman, Arie; Costa, Vera Marisa. "The cytotoxicity of doxorubicin, sunitinib and bortezomib in AC16 cardiac cells and possible therapeutic options involving redox pathways". Trabalho apresentado em SPF 2021 - 54th Meeting of Portuguese Society of Pharmacology, 42nd Meeting of the Clinical Pharmacology and 23rd Meeting of the Toxixology, Lisboa, 2024.
  2. Vitorino-Oliveira, Cláudia; Duarte-Araújo, Margarida; Carvalho, Félix; Costa, Vera Marisa. Autor correspondente: Costa, Vera Marisa. "The effect of the glutathione pathway on the cytotoxicity of sunitinib, doxorubicin and bortezomib in AC16 cells". Trabalho apresentado em XVII Meeting of Young Researchers of University of Porto, Porto, 2023.
    Publicado
  3. Vitorino-Oliveira, Cláudia; Valente, Sara; Lopes, Guido; Coimbra, Manuel; Passos, Cláudia. "Formulation of galactomannan microparticles from locust bean gum with insulin in the presence of endo-mannanase". Trabalho apresentado em Webinar: Development of tools to support the pulmonary route as a non-invasive alternative for drug delivery, 2022.
Artigo em revista
  1. Esteves-Monteiro, Marisa; Ferreira-Duarte, Mariana; Vitorino-Oliveira, Cláudia; Costa-Pires, José; Oliveira, Sara; Matafome, Paulo; Morato, Manuela; et al. Autor correspondente: Costa, Vera M. "Oxidative Stress and Histomorphometric Remodeling: Two Key Intestinal Features of Type 2 Diabetes in Goto–Kakizaki Rats". International Journal of Molecular Sciences 25 22 (2024): 12115. https://doi.org/10.3390/ijms252212115.
    Publicado • 10.3390/ijms252212115
  2. Reis-Mendes, Ana; Vitorino-Oliveira, Cláudia; Ferreira, Mariana; Carvalho, Félix; Remião, Fernando; Sousa, Emília; de Lourdes Bastos, Maria; Costa, Vera Marisa. "Comparative In Vitro Study of the Cytotoxic Effects of Doxorubicin’s Main Metabolites on Cardiac AC16 Cells Versus the Parent Drug". Cardiovascular Toxicology 24 3 (2024): 266-279. http://dx.doi.org/10.1007/s12012-024-09829-6.
    10.1007/s12012-024-09829-6
  3. Vitorino-Oliveira, Cláudia; Kahremany, Shirin; Nisim, Leon; Duarte-Araújo , Margarida; Carvalho, Félix; Gruzman, Arie; Costa, Vera Marisa. "Assessing the cytotoxic effects of sunitinib on AC16 cardiac cells and its potential association with autophagy". (2024): https://doi.org/10.48797/sl.2024.133.
    https://doi.org/10.48797/sl.2024.133
  4. Luís, Cláudia; Vitorino-Oliveira, Cláudia; Gaspar, Helena; Carvalho, Félix; Capela, João Paulo; Costa, Vera Marisa. "Comparing Cytotoxic Effects of Synthetic Cathinones and Methamphetamine on Cardiac AC16 Cell". (2024): https://doi.org/10.48797/sl.2024.251.
    https://doi.org/10.48797/sl.2024.251
Poster em conferência
  1. Luís, Cláudia; Vitorino-Oliveira, Cláudia; Gaspar, Helena; Carvalho, Félix; Capela, João Paulo; Costa, Vera Marisa. Autor correspondente: Luís, Cláudia. "Synthetic Cathinones vs Methamphetamine: A Comparative In Vitro Cytotoxicity Study on Cardiac AC16 Cells". Trabalho apresentado em IX Edição das Jornadas da Bioquímica do NEBQUP, 2024.
  2. Vitorino-Oliveira, Cláudia; Kahremany, Shirin; Nissim, Laura; Duarte-Araújo, Margarida; Carvalho, Félix; Gruzman, Arie; Costa, Vera Marisa. Autor correspondente: Vitorino-Oliveira, Cláudia. "A citotoxicidade do sunitinib, da doxorrubicina e do bortezomib nas células AC16 e possíveis terapias envolvendo as vias redox". Trabalho apresentado em 5º Encontro Nacional de Jovens Investigadores em Oncologia, 2023.
  3. Vitorino-Oliveira, Cláudia; Kahremany, Shirin; Nissim, Laura; Duarte-Araújo, Margarida; Carvalho, Félix; Gruzman, Arie; Costa, Vera Marisa. Autor correspondente: Vitorino-Oliveira, Cláudia. "The cytotoxicity of sunitinib, doxorubicin and bortezomib in AC16 cardiac cells and possible therapeutic oprtions involving redox pathways". Trabalho apresentado em 18th YES Meeting, 2023.
  4. Vitorino-Oliveira, Cláudia; Kahremany, Shirin; Nissim, Laura; Duarte-Araújo, Margarida; Carvalho, Félix; Costa, Vera Marisa. Autor correspondente: Costa, Vera Marisa. "The influence of oxidative stress modulators on the cytotoxicity of sunitinib, doxorubicin and bortezomib in AC16 cardiac cells". Trabalho apresentado em VIII Jornadas da Bioquímica, 2023.
Resumo em conferência
  1. Esteves-Monteiro, Marisa; Ferreira-Duarte, Mariana; Vitorino-Oliveira, Cláudia; Oliveira, Sara; Matafome, Paulo; Manuela Morato; Dias-Pereira Patrícia; Costa, Vera Marisa; Duarte-Araújo, Margarida. "Oxidative stress and histomorphometric gut remodeling in type 2 diabetic GK rats". Trabalho apresentado em 3rd International Meeting of the Portuguese Physiological Society, Porto, 2025.
    Publicado • 10.3389/978-2-8325-5124-0
Tese / Dissertação
  1. Cláudia Isabel Vitorino de Oliveira. "Nrf2 modulators as pharmacological strategies to tackle the cardiotoxicity of anti-cancer drugs: a cardio-oncology in vitro study in human cardiac AC16 cells". Mestrado, 2023. https://hdl.handle.net/10216/156805.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2025/02/07 Cardiotoxicity of Sunitinib: Insights into the impact on the autophagy pathway SPF 2025 55ª reunião da Sociedade Portuguesa de Farmacologia, 43ª reunião de Farmacologia Clínica, 24ª reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2024/02 The cytotoxicity of doxorubicin, sunitinib and bortezomib in AC16 cardiac cells and possible therapeutic options involving redox pathways SPF 2021 - 54th Meeting of Portuguese Society of Pharmacology, 42nd Meeting of the Clinical Pharmacology and 23rd Meeting of the Toxixology
(Lisboa, Portugal)
2023/05/12 The effect of the glutathione pathway on the cytotoxicity of sunitinib, doxrubicin and bortezomib in AC16 16th Meeting of Young Researchers of Univeristy of Porto
Universidade do Porto (Porto, Portugal)
2023/04/28 The influence of glutathione pathway modulators on the cytotoxicity of sunitinib, doxorubicin and bortezomib in AC16 cardiac cells II TOXRUN International Congress 2023
(Porto, Portugal)

Orientação

Título / Tema
Papel desempenhado
Curso (Tipo)
Instituição / Organização
2024/01 - Atual Characterization of an In Vitro Model of Human Heart Cells
Coorientador
Universidade do Porto Departamento de Química e Bioquímica, Portugal

Revisão ad hoc de artigos em revista

Nome da revista (ISSN) Editora
2023/12 - Atual Heliyon Elsevier

Tutoria

Tópico Nome do aluno
2023/06/02 - 2023/06/16 Student Exchange Programme (SEP) Alicja Lemanska
2023/06/02 - 2023/06/16 Student Exchange Programme (SEP) Maja Cvetanoska
Distinções

Prémio

2023 Oncology & Immunology Poster Session First Prize

Outra distinção

2024 Selected for oral presentation
Scientific Committee of III TOXRUN International congress 2024, Portugal
2023 Selected for oral presentation
Scientific Committee of II TOXRUN International congress 2023, Portugal